BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9633517)

  • 1. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
    Vikhanskaya F; Vignati S; Beccaglia P; Ottoboni C; Russo P; D'Incalci M; Broggini M
    Exp Cell Res; 1998 May; 241(1):96-101. PubMed ID: 9633517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL
    Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
    Wu GS; Ding Z
    Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
    Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K; Horwitz SB
    Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death.
    Sleiman RJ; Stewart BW
    Clin Cancer Res; 2000 Sep; 6(9):3756-65. PubMed ID: 10999770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
    Chen QM; Merrett JB; Dilley T; Purdom S
    Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
    Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
    Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
    Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells.
    Ling YH; Zou Y; Perez-Soler R
    Anticancer Res; 2000; 20(2A):693-702. PubMed ID: 10810342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs.
    Blagosklonny MV
    Oncogene; 2002 Sep; 21(41):6249-54. PubMed ID: 12214265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
    Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
    Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
    Ling YH; Yang Y; Tornos C; Singh B; Perez-Soler R
    Cancer Res; 1998 Aug; 58(16):3633-40. PubMed ID: 9721872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16-E6 enhances mitoxantrone sensitivity in a human ovarian cancer line: an isolated instance or a trend?
    Cimoli G; Valenti M; Ottoboni C; Parodi S
    Int J Oncol; 2001 Apr; 18(4):759-65. PubMed ID: 11251171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells.
    Ito K; Nakazato T; Miyakawa Y; Yamato K; Ikeda Y; Kizaki M
    J Cell Physiol; 2003 Aug; 196(2):276-83. PubMed ID: 12811820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.